Peptide Database
Evidence-rated profiles for research peptides — mechanism, protocols, side effects, and how much (or how little) research actually backs each one. Profiles are being added over time; not every peptide has a full write-up yet.
What the star rating means
The score reflects how much research exists and how far along it is — animal-only vs. human trials, research-stage vs. FDA approved — not how safe, effective, or worth trying a compound is. It is not my personal opinion of how good a peptide is, and not a recommendation. A low score means “understudied,” not “bad.” See each profile for the full breakdown.
Semaglutide
0.25–2.4 mg · Weekly
Tirzepatide
2.5–15 mg · Weekly
Retatrutide
1–12 mg · Weekly
SS31
1000 mcg · Mon-Fri (5x/week)
PT-141 (Bremelanotide)
1–2 mg · As needed (max 1×/72h)
Thymosin Alpha-1
1.5 mg · 2×/week
NAD+
50000 mcg · Mon/Wed/Fri
GHK-Cu
1700 mcg · Daily, PM
CJC-1295 (no DAC)
100 mcg · Daily or EOD
Ipamorelin
200–300 mcg · Daily or EOD
BPC-157/TB-500
500 mcg · Daily
Semax
250 mcg · Tue/Thu/Sat
BPC-157
250–500 mcg · Daily or ED
Selank
250–300 mcg · Daily
TB-500
2.5–5 mg · 2×/week loading, then weekly
Epithalon
5–10 mg · Daily for 10-day cycle
MotC
2 mg · Mon/Wed/Sat/Sun (4×/week)